All News

The results of the genomic data can guide treatment decisions post-surgery in prostate cancer.

Numbers for Stage 2 meaningful use attestation remain very low, according to the latest numbers from the Centers for Medicare and Medicaid Services.

The narrow health insurance networks that have become more common under the Affordable Care Act can reduce patient spending by as much as a third, according to research from MIT.

"Merck is threatening to exploit that invention," known as immunotherapy, with a later-developed method of treatment, in violation of a May 20 patent, Bristol-Myers said in a lawsuit filed yesterday in federal court in Wilmington, Delaware. The New York-based company is seeking unspecified damages.

Large businesses expect to pay between 4 and 5 percent more for health-care benefits for their employees in 2015 after making adjustments to their plans, according to employer surveys conducted this summer.

Writers in the recent issue of JAMA Dermatology call on the healthcare system to change the way the nation screens for melanoma, citing the $291 million annual cost of treating the disease and the $2.85 billion costs in lost productivity, which they say could be trimmed if cases were caught earlier.

Highmark, an insurer with its own health system, is challenging a growing and controversial billing practice that also happens to be a central part of some health system integration strategies.

The law could restrict the use of less-expensive generics with the availability of newer, more-expensive drugs.

In recent months, as the conversation about reforming the health care system has shifted to achieving greater delivery system efficiencies, cost containment, and patient satisfaction, the role of health care technology-specifically, telehealth and health information technology (health IT or HIT), is becoming an ever more prevalent discussion topic among health policy stakeholders.

Nearly a quarter of a million newly naturalized citizens or immigrants may lose their health insurance coverage under the Affordable Care Act at the end of the month.

Researchers at the George Washington University (GW) were awarded a grant estimated to be funded at $23.8 million from the Centers for Medicare & Medicaid Services (CMS) to study a new model that aims to improve HIV prevention and care while lowering healthcare costs.

Although family history is a risk factor, a new study has shown that it should not be the primary determinant of mutation screening for breast and ovarian cancer.

Growing up in a smoke-free home is now the overwhelming norm for most Americans, with the share of smoke-free homes nearly doubling in the 20 years that ended in 2011, the Centers for Disease Control and Prevention said today in a new study. Overall, the prevalence of smoke-free home rules increased from 43 percent during 1992—1993 to 83 percent during 2010—2011, according to the study, which appears in today's Mortality and Morbidity Weekly Report, published by CDC.

The write believes that the episodic reimbursement model might introduce bias among radiation oncologists who own their own treatment equipment.

The Government says the site did not carry any personal information on consumers.

Transitional plans that are non-compliant may be cancelled by the insurer or barred by some states.

Does $50,000 per quality-adjusted life year (QALY) hold value in today's age of high-priced specialty drugs? The authors evaluate this yardstick and recommend changes that could aid cost-effectiveness decisions.

If diabetes rates continue to rise out of control, the present downward trajectory in global TB cases could be offset by 8% (ie, 8% less reduction) or more by 2035, warn the authors of a new article.

Yesterday's government report that healthcare spending will start rising faster after a decade of historically slow growth raises questions: Will rising numbers of insured people drive the spending? Or are healthcare costs going up on their own? The answer is likely some of each, based on a look at trends within yesterday's report and a just-released study of spending by commercial health plans, published in The American Journal of Managed Care.

The White House named former Google executive Megan Smith as its new chief technology officer to succeed Athenahealth co-founder and HHS veteran Todd Park, who is credited with helping rescue HealthCare.gov.

Following a breakthrough therapy designation, pembrolizumab was included in FDA's accelerated approval program to allow early patient access.

While Sovaldi is still fresh on the mind, Ono Pharmaceutical's Opdivo (nivolumab), marketed jointly with BMS in Japan, has analysts projecting what the treatment might cost in the US.

The Appeals Court for the District of Columbia announced Thursday that it would re-hear Halbig v. Burwell en banc, meaning the entire panel of 11 judges will weigh in on the case. There will also be two senior judges who hear the case, but do not vote.

Maine is one of twenty-three states nationally to stay away from Medicaid Expansion.

Survival at 10 years was no better when women had double mastectomies.

The guidelines suggest various treatment options available, following consideration of the patient's status and preference.

The economy's lackluster recovery eroded wages and left millions chronically unemployed. It also offered significant relief from the fiscal distress of U.S. health spending. Now, spending fueled by the improving economy and the healthcare reform law's insurance and Medicaid expansions are likely to turn that around.

Despite what some media reports have to say, health insurance premiums won't "skyrocket" next year, according to an article by ConsumerReports.

States who refused to expand Medicaid will pay for other states that did; an investment without returns unless they participate in the expansion program.

The program is being developed to treat metastatic prostate cancer.